Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hyun-Jun Youn"'
Autor:
Soo-Hyoung Kang, Yoon Ji Kim, Won-Sik Shim, Hyun-Jun Youn, Tae Hyoung Kim, Ghun-Il Lee, Hyun-Hee Kwak, Chang-Koo Shim, Mi-Kyung Son, Zee-Hye Yoon, Seong-Mee Hwang
Publikováno v:
Pharmaceutical Research. 26:2504-2512
To develop an improved sustained-release (SR) formulation of exenatide (a therapy for patients with type 2 diabetes mellitus) in a biweekly dosage form with therapeutic efficacy comparable to that achieved with twice-daily injections of the drug.A SR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c8a1119e2608da3ef40267472cfd91
https://doi.org/10.1007/s11095-009-9966-3
https://doi.org/10.1007/s11095-009-9966-3
Autor:
Jae-Hoon Chang, Hyun-Jun Youn, Chang-Yuil Kang, Ah-Young Lee, Ho-Youn Kim, Mi-Na Kweon, Masaru Taniguchi, Kyoo-A Lee, Jung-Mi Lee, Yeonseok Chung
Publikováno v:
European Journal of Immunology. 38:2727-2739
We previously showed that although systemic administration of alpha-galactosylceramide (alphaGalCer) or agonistic anti-CD40 induced functional maturation of dendritic cells (DC) in mesenteric lymph nodes, only the former treatment succeeded in breaki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::667f82502b71ec2f1b8e3221ee51d3fe
https://doi.org/10.1002/eji.200838159
https://doi.org/10.1002/eji.200838159
Autor:
Hyun-Jeong Ko, Mi-Na Kweon, Sung-Youl Ko, Hyun-Jun Youn, Chang-Yuil Kang, Kyoo-A Lee, Yeon-Jeong Kim, Tae-Hwe Heo
Publikováno v:
European Journal of Immunology. 37:2127-2137
Our previous study revealed that alpha-galactosylceramide (alpha-GalCer) is a potent nasal vaccine adjuvant inducing both potent humoral and cellular immune responses and affording complete protection against viral infections and tumors. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2083c02269f680f1d4dc6168b6bd0d6
https://doi.org/10.1002/eji.200636909
https://doi.org/10.1002/eji.200636909
Autor:
Chang-Yuil Kang, Dong Jae Baek, Sung-Youl Ko, Sanghee Kim, Hyun-Jun Youn, Won-Jea Cho, Tae-Ho Lee, Minjae Cho
Publikováno v:
Journal of Medicinal Chemistry. 50:585-589
alpha-GalCer is the first defined and most potent agonistic antigen of the T cell receptor of natural killer T cells. We have prepared a series of 1,2,3-triazole-containing alpha-GalCer analogues in which the lipid chain lengths have been incremental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::739561b2ca9dfcedd067c3f9a8d5f8f0
https://doi.org/10.1021/jm061243q
https://doi.org/10.1021/jm061243q
Autor:
Sung-Youl Ko, Hyun-Jeong Ko, Prosper N. Boyaka, Yoon-Sook Lee, Kohtaro Fujihashi, Chang-Yuil Kang, Taisuke Horimoto, Sanghee Kim, Kyoo-A Lee, Mi-Na Kweon, Hyun-Jun Youn
Publikováno v:
Vaccine. 25(28)
alpha-Galactosylceramide (alpha-GalCer), originally isolated from a marine sponge, was known to activate natural killer T (NKT) cells through CD1d-mediated Ag presentation and induce Th1 and/or Th2 immunity. In this study, we evaluated the nasal adju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d002e8b62ce92a6f4169013d76bf89
https://pubmed.ncbi.nlm.nih.gov/17548137
https://pubmed.ncbi.nlm.nih.gov/17548137
Autor:
Taeho Lee, Minjae Cho, Sung-Youl Ko, Hyun-Jun Youn, Dong Jae Baek, Won-Jea Cho, Chang-Yuil Kang, Sanghee Kim
Publikováno v:
Journal of Medicinal Chemistry; Feb2007, Vol. 50 Issue 3, p585-589, 5p